Erasca, Inc. (ERAS)
17.61
-0.02
(-0.11%)
USD |
NASDAQ |
Aug 24, 16:00
17.61
0.00 (0.00%)
After-Hours: 19:17
Erasca Max Drawdown (5Y) : 95.64% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 95.64% |
| June 30, 2026 | 95.64% |
| May 31, 2026 | 95.64% |
| April 30, 2026 | 95.64% |
| March 31, 2026 | 95.64% |
| February 28, 2026 | 95.64% |
| Date | Value |
|---|---|
| January 31, 2026 | 95.64% |
| December 31, 2025 | 95.64% |
| November 30, 2025 | 95.64% |
| October 31, 2025 | 95.64% |
| September 30, 2025 | 95.64% |
| August 31, 2025 | 95.64% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Revolution Medicines, Inc. | 73.29% |
| Tango Therapeutics, Inc. | 93.64% |
| Cogent Biosciences, Inc. | 94.16% |
| Apogee Therapeutics, Inc. | -- |
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -12.60 |
| Beta (5Y) | 0.6593 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 109.2% |
| Historical Sharpe Ratio (5Y) | -0.0598 |
| Historical Sortino (5Y) | -0.1713 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.73% |